erlotinib has been researched along with andrographolide in 2 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (andrographolide) | Trials (andrographolide) | Recent Studies (post-2010) (andrographolide) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 923 | 9 | 736 |
| Protein | Taxonomy | erlotinib (IC50) | andrographolide (IC50) |
|---|---|---|---|
| Bile acid receptor | Homo sapiens (human) | 9.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, M; Digwal, CS; Pandya, AN; Pandya, DH; Patel, S; Sharma, JA; Vasu, KK | 1 |
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
1 review(s) available for erlotinib and andrographolide
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
1 other study(ies) available for erlotinib and andrographolide
| Article | Year |
|---|---|
Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; HeLa Cells; Humans; NF-kappa B; Pyridines; Structure-Activity Relationship; Thiazoles; Thiophenes | 2017 |